Vicarious Surgical Stock Performance
| RBOT Stock | USD 10.31 0.27 2.69% |
Vicarious Surgical holds a performance score of 14 on a scale of zero to a hundred. The entity has a beta of 1.73, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vicarious Surgical will likely underperform. Use Vicarious Surgical downside variance, and the relationship between the total risk alpha and daily balance of power , to analyze future returns on Vicarious Surgical.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vicarious Surgical are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Vicarious Surgical unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.69 | Five Day Return 25.12 | Year To Date Return (25.51) | Ten Year Return (96.48) | All Time Return (96.48) |
Last Split Factor 1:30 | Last Split Date 2024-06-13 |
1 | Vicarious Surgical Nears Clinical Milestone with Innovative Surgical System RBOT Stock News | 05/12/2025 |
2 | Vicarious Surgical Inc Q1 2025 Earnings Call Highlights Strategic Partnerships and ... | 05/13/2025 |
3 | Disposition of 817 shares by Adam Sachs of Vicarious Surgical at 7.5277 subject to Rule 16b-3 | 05/20/2025 |
4 | Disposition of 463 shares by Adam Sachs of Vicarious Surgical at 7.2193 subject to Rule 16b-3 | 06/03/2025 |
5 | Vicarious Surgical CEO Adam Sachs sells 3,342 in stock - Investing.com | 06/04/2025 |
6 | Disposition of 1737 shares by Kelly William John of Vicarious Surgical at 373.5 subject to Rule 16b-3 | 06/05/2025 |
7 | Disposition of 223 shares by Sammy Khalifa of Vicarious Surgical at 7.8145 subject to Rule 16b-3 | 06/23/2025 |
8 | Disposition of 535 shares by Adam Sachs of Vicarious Surgical at 10.2791 subject to Rule 16b-3 | 07/14/2025 |
| Begin Period Cash Flow | 53.8 M | |
| Total Cashflows From Investing Activities | 6.9 M | |
| Free Cash Flow | -50.1 M |
Vicarious | Build AI portfolio with Vicarious Stock |
Vicarious Surgical Relative Risk vs. Return Landscape
If you would invest 534.00 in Vicarious Surgical on April 21, 2025 and sell it today you would earn a total of 497.00 from holding Vicarious Surgical or generate 93.07% return on investment over 90 days. Vicarious Surgical is currently generating 1.2604% in daily expected returns and assumes 6.761% risk (volatility on return distribution) over the 90 days horizon. In different words, 60% of stocks are less volatile than Vicarious, and 75% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vicarious Surgical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vicarious Surgical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vicarious Surgical, and traders can use it to determine the average amount a Vicarious Surgical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1864
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | RBOT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.76 actual daily | 60 60% of assets are less volatile |
Expected Return
| 1.26 actual daily | 25 75% of assets have higher returns |
Risk-Adjusted Return
| 0.19 actual daily | 14 86% of assets perform better |
Based on monthly moving average Vicarious Surgical is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vicarious Surgical by adding it to a well-diversified portfolio.
Vicarious Surgical Fundamentals Growth
Vicarious Stock prices reflect investors' perceptions of the future prospects and financial health of Vicarious Surgical, and Vicarious Surgical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vicarious Stock performance.
| Return On Equity | -1.04 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 37.3 M | ||||
| Shares Outstanding | 5.28 M | ||||
| Price To Earning | 8.61 X | ||||
| Price To Book | 1.79 X | ||||
| EBITDA | (61.12 M) | ||||
| Net Income | (63.22 M) | ||||
| Cash And Equivalents | 126.8 M | ||||
| Cash Per Share | 1.04 X | ||||
| Total Debt | 13.79 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 11.25 X | ||||
| Book Value Per Share | 5.75 X | ||||
| Cash Flow From Operations | (49.96 M) | ||||
| Earnings Per Share | (10.44) X | ||||
| Market Capitalization | 61.16 M | ||||
| Total Asset | 67.72 M | ||||
| Retained Earnings | (195.94 M) | ||||
| Working Capital | 44.03 M | ||||
About Vicarious Surgical Performance
Assessing Vicarious Surgical's fundamental ratios provides investors with valuable insights into Vicarious Surgical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Vicarious Surgical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.93) | (0.89) | |
| Return On Capital Employed | (1.11) | (1.16) | |
| Return On Assets | (0.93) | (0.89) | |
| Return On Equity | (1.35) | (1.29) |
Things to note about Vicarious Surgical performance evaluation
Checking the ongoing alerts about Vicarious Surgical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vicarious Surgical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vicarious Surgical is way too risky over 90 days horizon | |
| Vicarious Surgical appears to be risky and price may revert if volatility continues | |
| Vicarious Surgical has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (63.22 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vicarious Surgical currently holds about 126.8 M in cash with (49.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04. | |
| Vicarious Surgical has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from MacroaxisInsider: Disposition of 535 shares by Adam Sachs of Vicarious Surgical at 10.2791 subject to Rule 16b-3 |
- Analyzing Vicarious Surgical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vicarious Surgical's stock is overvalued or undervalued compared to its peers.
- Examining Vicarious Surgical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vicarious Surgical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vicarious Surgical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vicarious Surgical's stock. These opinions can provide insight into Vicarious Surgical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.